Trials / Completed
CompletedNCT02072655
Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University Hospital, Angers · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In the early 2000s , professional and patient organizations are mobilizing to highlight the psychosocial impact of cancer disease , not only during but also after the acute phase. In 2003, the government launched the Cancer Plan I reinforced in December 2011 by the Cancer Plan II whose objectives include : " Develop a personalized care taking into account the pain and psychological and social support " and " increase opportunities for patients to benefit from supportive care "and" promote the professional integration . This study aims to show that beyond the immediate benefits of the social aesthetic cares in hospital (direct soothing, improving the quality of the skin injured by chemotherapy , feeling of escape ... ), these treatments can also affect quality of life for patients during and after hospitalization. They also may have an impact on the maintenance of social and / or professional satisfactory throughout the planned chemotherapy aplastic period .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | socio-aesthetic care | * care of the face * skin cleansing with cleansing milk to remove impurities * a gentle scrub to exfoliate and cleanse the skin * a relaxing massage * moisturizing mask * application of a moisturizer suited to specific patient skin: skin reactivity, dehydration ... * care manicure / pedicure, * massages * makeup, advice (scarves, wigs care products adapted to the skin changes ...) and helping relationship. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-02-26
- Last updated
- 2016-06-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02072655. Inclusion in this directory is not an endorsement.